Biospace Lab Collaborates With ImaBio Group to Develop a Unique X-Ray Tomographic Module for its Preclinical Imaging System
PARIS, December 6, 2011 /PRNewswire/ --
Biospace Lab and the ImaBio Group (IPHC, Strasbourg) are pleased to announce they are collaborating on the development of a new X-ray tomographic imaging module for use with the Biospace Lab PhotonIMAGER™ OPTIMA system, a fully modular and versatile preclinical optical imager developed for real-time in vivo luminescence or fluorescence studies. The new add-in module will be faster than current Micro CT systems and will provide more information on organs and tissues, while delivering a low radiation dose compatible with longtitudinal animal studies. Co-registration of anatomical data with optical data will help increase the reliability and accuracy of the functional data acquired.
"As multimodality becomes more and more important for the development of optical imaging systems, such multi-disciplinary collaborations are essential to better serve the needs of Life Science research. ImaBio's expertise in the development of multi-modal imaging systems offers a great opportunity for us to jointly develop an additional add-in module for the PhotonIMAGER™ OPTIMA system that is totally unique in its technology and performance," says Olivier Merle, CEO of Biospace Lab.
"This collaboration reflects our desire to make bio-medical imaging a performing technology. We are very pleased to work together with Biospace Lab, whose PhotonIMAGER™ system plays an important role in our research projects as well as improving the visibility of our laboratory imaging platform today," says David Brasse, head of the ImaBio group.
About Biospace Lab
Based in Paris, France, Biospace Lab S. A. designs and develops a unique range of scientific instruments dedicated to real-time preclinical imaging for in vivo and ex vivo applications in small animals. Biospace Lab has developed a comprehensive portfolio of innovative solutions for ex vivo, in vivo and now in actio molecular imaging; which are used by almost every major pharmaceutical company and many prestigious academic research institutes worldwide.
About ImaBio
The ImaBio group, created in 2001, uses the different skills developed for High Energy Physics experiments at the Institut Pluridisciplinaire Hubert Curien (IPHC, UMR 7178), (University of Strasbourg, and the CNRS, the French National Scientific Research Center). The group activity splits into two domains, the development of per-operating tools to assist surgeon (in breast cancer treatment for example), and the design of A Multi Modality Imaging System for Small Animal (AMISSA) (µCT, µSPECT, µPET).
Share this article